Institutional Repository of Peking University School of Basic Medical Sciences
学科主题 | 基础医学 |
Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation | |
Dong, Shuying1; Kong, Jian1; Kong, Fandong5,6; Kong, Jinge5,6; Gao, Jun1; Ji, Liang2,3,4; Pan, Bing2,3,4; Chen, Lian7; Zheng, Lemin2,3,4; Sun, Wenbing1 | |
关键词 | Hepatocellular carcinoma Insufficient radiofrequency ablation Epithelial-mesenchymal transition Sorafenib |
刊名 | BMC CANCER
![]() |
2015-11-30 | |
DOI | 10.1186/s12885-015-1949-7 |
卷 | 15 |
收录类别 | SCI |
文章类型 | Article |
WOS标题词 | Science & Technology |
类目[WOS] | Oncology |
资助者 | Dr. Jieping Wu Medical Foundation ; Program for Medical Key Discipline of Shijingshan District, Beijing ; "973" National ST Major Project ; National Natural Science Foundation of China ; Natural Science Foundation of Beijing, China ; Dr. Jieping Wu Medical Foundation ; Program for Medical Key Discipline of Shijingshan District, Beijing ; "973" National ST Major Project ; National Natural Science Foundation of China ; Natural Science Foundation of Beijing, China |
研究领域[WOS] | Oncology |
关键词[WOS] | RAPID PROGRESSION ; PATHWAYS ; CHEMOEMBOLIZATION ; METASTASIS ; INHIBITION ; THERAPY ; CANCER |
英文摘要 | Background: Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used to suppress the EMT of HCC after insufficient RFA and further prevent the progression of residual HCC remains poorly unknown. Methods: Insufficient RFA was simulated using a water bath (47 degrees C 5, 10, 15, 20 and 25 min gradually). MTT assay and transwell assay were used to evaluate the effects of sorafenib on viability, migration and invasion of HepG2 and SMMC7721 cells after insufficient RFA in vitro. After insufficient RFA, the molecular changes in HCC cells with the treatment of sorafeinb were evaluated using western blot and ELISAs. An ectopic nude mice model was used to evaluate the effect of sorafenib on the growth of HepG2 cells in vivo after insufficient RFA. Results: HepG2 and SMMC7721 cells after insufficient RFA (named as HepG2-H and SMMC7721-H) exhibited enhanced viability, migration and invasion in vitro. Sorafenib inhibited the enhanced viability, migration and invasion of HepG2 and SMMC7721 cells after insufficient RFA. Molecular changes of EMT were observed in HepG2-H and SMMC7721-H cells. Sorafenib inhibited the EMT of HepG2-H and SMMC7721-H cells. HepG2-H cells also exhibited larger tumor size in vivo. Higher expression of PCNA, Ki67, N-cadherin, MMP-2 and MMP-9, was also observed in HepG2-H tumors. Sorafenib blocked the enhanced growth of HepG2 cells in vivo after insufficient RFA. Conclusions: Sorafenib inhibited the EMT of HCC cells after insufficient RFA, and may be used to prevent the progression of HCC after RFA. |
语种 | 英语 |
所属项目编号 | 320675007131 ; 32067501207 ; 2011CB503900 ; 81170101 ; 81370235 ; 81572957 ; 81502650 ; 7122106 |
资助者 | Dr. Jieping Wu Medical Foundation ; Program for Medical Key Discipline of Shijingshan District, Beijing ; "973" National ST Major Project ; National Natural Science Foundation of China ; Natural Science Foundation of Beijing, China ; Dr. Jieping Wu Medical Foundation ; Program for Medical Key Discipline of Shijingshan District, Beijing ; "973" National ST Major Project ; National Natural Science Foundation of China ; Natural Science Foundation of Beijing, China |
WOS记录号 | WOS:000365490400001 |
Citation statistics | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.bjmu.edu.cn/handle/400002259/63140 |
Collection | 北京大学基础医学院 |
作者单位 | 1.Capital Med Univ, Beijing Chao Yang Hosp, Dept Hepatobiliary Surg, Beijing 100043, Peoples R China 2.Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100191, Peoples R China 3.Peking Univ, Hlth Sci Ctr, Key Lab Mol Cardiovasc Sci, Minist Educ,Inst Cardiovasc Sci, Beijing 100191, Peoples R China 4.Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing 100191, Peoples R China 5.Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Dept Neurobiol, Beijing 100191, Peoples R China 6.Peking Univ, Natl Hlth & Family Planning Commiss, Minist Educ, Key Lab Neurosci, Beijing 100191, Peoples R China 7.Fujian Med Univ, Affiliated Mindong Hosp, Dept Orthopaed 8, Fuzhou 355000, Fujian, Peoples R China |
Recommended Citation GB/T 7714 | Dong, Shuying,Kong, Jian,Kong, Fandong,et al. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation[J]. BMC CANCER,2015,15. |
APA | Dong, Shuying.,Kong, Jian.,Kong, Fandong.,Kong, Jinge.,Gao, Jun.,...&Sun, Wenbing.(2015).Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.BMC CANCER,15. |
MLA | Dong, Shuying,et al."Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation".BMC CANCER 15(2015). |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment